| 1 |
23169295 | Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer. | 2012 Dec 4 |
1 |
| 2 |
17097873 | Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin. | 2007 Jan |
3 |
| 3 |
15025795 | Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer. | 2004 Feb |
1 |
| 4 |
15222105 | [Tumoral dihydropyrimidine dehydrogenase expression and efficacy of 5-fluorouracil plus leucovorin plus UFT therapy in patients with colorectal cancer]. | 2004 Jun |
1 |
| 5 |
11977552 | [A case of liver metastasis of rectal cancer demonstrating complete response to 5-FU + Leucovorin + UFT]. | 2002 Apr |
1 |
| 6 |
12006517 | Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition. | 2002 May |
5 |
| 7 |
11241325 | UFT plus oral leucovorin calcium (Orzel) and radiation in combined modality therapy: a comprehensive review. | 2001 Feb 20 |
1 |
| 8 |
11459999 | Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. | 2001 Jul |
2 |
| 9 |
10778957 | Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. | 2000 Apr |
2 |
| 10 |
10874920 | [Metastatic colorectal cancer: new therapeutics]. | 2000 May 27-Jun 3 |
2 |
| 11 |
11081569 | The tegafur-based dihydropyrimidine dehydrogenase inhibitory fluoropyrimidines, UFT/leucovorin (ORZEL) and S-1: a review of their clinical development and therapeutic potential. | 2000 Nov |
2 |
| 12 |
9264323 | Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor. | 1997 Jun 1 |
1 |